U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H5NOS
Molecular Weight 91.132
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-MERCAPTOACETAMIDE

SMILES

NC(=O)CS

InChI

InChIKey=GYXHHICIFZSKKZ-UHFFFAOYSA-N
InChI=1S/C2H5NOS/c3-2(4)1-5/h5H,1H2,(H2,3,4)

HIDE SMILES / InChI

Molecular Formula C2H5NOS
Molecular Weight 91.132
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Effect of gadolinium chloride on liver regeneration following thioacetamide-induced necrosis in rats.
2010-11-04
Changes in rosacea comorbidities and treatment utilization over time.
2010-11
N-{[4-(4-Meth-oxy-benzene-sulfonamido)-phen-yl]sulfon-yl}acetamide.
2010-06-23
A study on the incidence, microbiological analysis and investigations on the source of infection of postoperative infectious endophthalmitis in a tertiary care ophthalmic hospital: an 8-year study.
2010-06-11
The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses.
2010-03
Fluoroalkene modification of mercaptoacetamide-based histone deacetylase inhibitors.
2010-01-15
N-[4-(p-Toluenesulfonamido)phen-ylsulfon-yl]acetamide.
2010-01-09
Rosacea: a review of current topical, systemic and light-based therapies.
2009-12
A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.
2009-10
The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris.
2009-08
An update on the management of acne vulgaris.
2009-06-17
Botulinum neurotoxin serotype A inhibitors: small-molecule mercaptoacetamide analogs.
2009-04-15
A case of amniotic membrane transplantation in non-healing Nocardia asteroides keratitis.
2009-03-10
Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam.
2009-03
Synthesis of CdS nanorods in soft template under gamma-irradiation.
2009-02
Peroxisome proliferator-activated receptors in HCV-related infection.
2009
The cost-effectiveness of rosacea treatments.
2009
In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors.
2008-09-01
Effective over-the-counter acne treatments.
2008-09
Antimicrobial prescribing trends in primary care: implications for health policy in Bahrain.
2008-04
Chemistry, biology, and QSAR studies of substituted biaryl hydroxamates and mercaptoacetamides as HDAC inhibitors-nanomolar-potency inhibitors of pancreatic cancer cell growth.
2008-03
Effects of some antibiotics on human erythrocyte glutathione reductase: an in vitro study.
2008-02
Development and evaluation of a chloramphenicol hypertonic ophthalmic solution.
2008-01
Researches concerning the synthesis and antituberculosis action of some new sulphacetamide derivatives.
2007-09-07
A novel arginine methyltransferase inhibitor with cellular activity.
2007-08-01
Pilot investigation of the hydrating effects of topical acne medications.
2007-08
Functional differences in epigenetic modulators-superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies.
2007-06-28
Determination of sulfonamides in milk after precolumn derivatisation by micellar liquid chromatography.
2007-06-19
Effects of some drugs on hepatic glucose 6-phosphate dehydrogenase activity in Lake Van fish (Chalcalburnus tarischii Pallas, 1811).
2007-05-08
Epidermal growth factor receptor (EGFR) inhibitor associated skin eruption.
2006-04
Refractory Demodex folliculitis in five children with acute lymphoblastic leukemia.
2005-09-30
Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea.
2005-06
The pharmacologic therapy of rosacea: a paradigm shift in progress.
2005-03
Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design.
2005-01-17
Synthesis and valuation of mannich bases of certain novel nitro hydroxy 1, 2 - pyrazolines.
2004-10
The use of sulfur in dermatology.
2004-08-12
Actinomyces canaliculitis: diagnosis of a masquerading disease.
2004-08
A double-blind comparative study of sodium sulfacetamide lotion 10% versus selenium sulfide lotion 2.5% in the treatment of pityriasis (tinea) versicolor.
2004-06
Incorporation of chemoselective functionalities into peptoids via solid-phase submonomer synthesis.
2004-03-18
Rosac Cream With Sunscreens (sodium sulfacetamide 10% and sulfur 5%).
2004-03-11
Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations.
2004-01
Spectrophotometric determination of sulphacetamide.
2002-11-13
Post-translational modification detection using metastable ions in reflector matrix-assisted laser desorption/ionization-time of flight mass spectrometry.
2002-10
Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.
2001-02
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:32:46 GMT 2025
Edited
by admin
on Mon Mar 31 19:32:46 GMT 2025
Record UNII
512243B4TP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-524366
Preferred Name English
2-MERCAPTOACETAMIDE
Systematic Name English
.ALPHA.-MERCAPTOACETAMIDE
Systematic Name English
MERCAPTOACETAMIDE
Systematic Name English
THIOGLYCOLAMIDE
Systematic Name English
THIOLACETAMIDE
Systematic Name English
ACETAMIDE, 2-MERCAPTO-
Systematic Name English
Code System Code Type Description
CAS
758-08-7
Created by admin on Mon Mar 31 19:32:46 GMT 2025 , Edited by admin on Mon Mar 31 19:32:46 GMT 2025
PRIMARY
PUBCHEM
12961
Created by admin on Mon Mar 31 19:32:46 GMT 2025 , Edited by admin on Mon Mar 31 19:32:46 GMT 2025
PRIMARY
NSC
524366
Created by admin on Mon Mar 31 19:32:46 GMT 2025 , Edited by admin on Mon Mar 31 19:32:46 GMT 2025
PRIMARY
FDA UNII
512243B4TP
Created by admin on Mon Mar 31 19:32:46 GMT 2025 , Edited by admin on Mon Mar 31 19:32:46 GMT 2025
PRIMARY
EPA CompTox
DTXSID30226711
Created by admin on Mon Mar 31 19:32:46 GMT 2025 , Edited by admin on Mon Mar 31 19:32:46 GMT 2025
PRIMARY